Stereotactic radiosurgery, known for efficacy in the noninvasive treatment of tumors or
|
|
- Nathaniel Morris
- 5 years ago
- Views:
Transcription
1 NEUROLOGICAL REVIEW SECTION EDITOR: DAVID E. PLEASURE, MD Stereotactic Radiosurgery for Treatment of Epilepsy Mark Quigg, MD, MSc; Nicholas M. Barbaro, MD Stereotactic radiosurgery, known for efficacy in the noninvasive treatment of tumors or arteriovenous malformations that are otherwise difficult to access through traditional surgery, is an emerging technology in the treatment of focal epileptic lesions. Recent studies in the treatment of hypothalamic hamartoma and mesial temporal lobe epilepsy further suggest that seizures in these medically intractable syndromes remit at clinically significant rates with stereotactic radiosurgery. Further studies will be required to determine whether efficacy attains that of traditional surgery while offering a noninvasive technique with potentially lower morbidity. Arch Neurol. 2008;65(2): Stereotactic surgery, in particular with the Gamma Knife (Elekta AB, Stockholm, Sweden), allows precise radiosurgical lesions to be administered to the nervous system in locations that cannot be accessed easily by conventional surgical approaches. In addition, its ability to target physiologic lesions noninvasively may be advantageous for selected patients. In association with epilepsy, Gamma Knife surgery (GKS) is most often used in the treatment of symptomatic lesions such as tumors or vascular malformations; epilepsy in these cases is often one of several presenting symptoms and often improves as a benefit of the treatment of the lesion. Recently, the use of GKS has expanded into the treatment of previously inoperable hypothalamic hamartomas (HHs) and physiologic lesions such as mesial temporal lobe epilepsy (MTLE). This review will outline the radiosurgical treatment of epilepsy with special attention to MTLE. THE GAMMA KNIFE DEVICE In 1951, Leksell, a Swedish neurosurgeon, reported the first stereotactic radiosurgery. 1 By 1967, the first Gamma Knife Author Affiliations: Department of Neurology, University of Virginia, Charlottesville (Dr Quigg); Departments of Neurology and Neurological Surgery, University of California, San Francisco (Dr Barbaro). device was installed in Karolinska Hospital, Stockholm, Sweden. The current device contains 201 cobalt 60 sources contained in a shielded array. Gamma radiation is focused through apertures (collimators) within a hemispheric helmet. The principle of GKS is that, whereas individual sources of radiation are too weak to damage intervening brain tissue, targets within the common focus are exposed to high-intensity radiation. The total absorbed dose (measured in gray) and volume of gamma radiation are adjustable in the size of the collimators or the duration of each exposure (dose isocenters). The shape of the treatment area can be adjusted to conform to the anatomic target or to protect nearby structures by combining treatment isocenters or by plugging individual collimators. EXPERIMENTAL MODELS AND MECHANISMS OF GAMMA IRRADIATION Investigations of the effects of focal irradiation on epileptic lesions in experimental animal models of partial epilepsy are few but carry some common findings that are important when evaluating trials of GKS in human epilepsy. First, experimental models of focal epilepsy demonstrate that destruction of neu- 177
2 ronal tissue through radionecrosis is not required for amelioration of seizures or their experimental surrogates. Second, seizure response, either in successful remission or in a paradoxical worsening, varies with target, dose, or postoperative duration. Third, the treatment target, dose, and volume remain empirically determined, and scaling up from experimental models to humans is not straightforward. It is not known how gamma irradiation produces an antiepileptic effect. Sensitivity to ionizing irradiation is largely dependent on mitotic rate; therefore, neurons are relatively radioresistant. In flurothyl-kindled mice, although total brain irradiation terminates seizureinduced mitotic activity in hippocampal dentate gyri, irradiated mice have no changes in seizure threshold or clinical seizure phenotype. Therefore, the differences in mitotic activity in epileptic areas may not underlie antiepileptic effect. 2 Tissue necrosis is not necessary. 3-6 Histologic examination of irradiated rat hippocampi shows changes of experimental hippocampal sclerosis rather than changes typical of acute or chronic severe radiation injury. 3-6 Although neurons themselves are resistant to radionecrosis, supporting structures vasculature and glia are not. The major pathological findings after irradiation consist of endothelial damage to small blood vessels and astrocytic reactions. One hypothesis, therefore, is that neuronal damage results from ischemia caused by vascular inflammation. Other hypotheses suggest that irradiated neuronal circuits undergo neuromodulation that renders an anticonvulsant (or, sometimes, a paradoxically proconvulsant) effect. Differential susceptibility to irradiation or ischemia among different neuronal populations within epileptogenic circuits may account for this phenomenon. 7 Given these possible mechanisms, studies with the use of well-validated models of partial epilepsy address some of the questions of target, administration, time course, and clinical sequelae. These models include electrically kindled rats 3,8 studied through surrogate markers of triggered seizure threshold and severity, as well as rat models that experience spontaneous seizures induced either by kainic acid 5,6 or by electrically provoked, selfsustained limbic status epilepticus. 4 The earliest of these series established that there might be a proconvulsant or anticonvulsant effect of GKS that varies with postoperative duration or dose. Kindled rats with doses of 25 Gy or less to the amygdala experience clinically more intense seizures. 8 Kindled rats treated with 40 Gy to a single hippocampus initially experience a decrease in seizure threshold compared with controls within the first month. Thereafter, however, treated animals develop increased seizure thresholds. 3 Other experiments established relationships between dose and latency with experimental spontaneously occurring seizures. 4-6 In animals monitored for 6 weeks, doses of 80 and 100 Gy cause seizure reductions within 2 to 4 weeks postoperatively, whereas lesser doses cause reductions of slower onset. 6 Increasing doses of radiosurgery correlate with higher percentages of rats that became seizure-free. 6 Other studies indicate that there is a threshold effect, with single treatments of 30 Gy being as effective as 60 Gy in reducing seizures. 5 This suggests that, once a tissue-damaging level has been reached, there is little advantage in increasing the radiation dose. Longterm electroencephalogram monitoring for periods of up to 10 months establishes that the anticonvulsant effects of GKS are durable. 4 In summary, it seems clear from the preclinical literature that there is a dose-dependent response to radiation. These experiments help define a therapeutic window of treatment dose bounded by ineffectiveness, paradoxic exacerbation, or delayed remission at the lower doses and by tissue necrosis at higher doses. Evaluation of human studies, therefore, requires particular attention to treatment dose, volume, and target. TREATMENT OF LESIONAL EPILEPSY The anticonvulsant benefits of GKS were first observed as additional benefits during its use as a treatment of tumors 9 or arteriovenous malformations (AVMs) Supratentorial Tumors Given the variety of types, pathological features, and locations of central nervous system tumors, the studies of effects of GKS on tumor-associated epilepsy are few. Schröttner et al, 9 however, concentrated on patients with medically intractable epilepsy resulting from tumors, dividing 24 patients into 2 groups by the amount of radiation directed to surrounding tissue. Outcome was retrospectively ranked at mean duration of approximately 2 years as excellent (Engel class 1 or 2) or not. Patients in the high-dose group achieved a 66% improvement rate compared with 42% for the low-dose group. Because all patients achieved tumor control with GKS (thus removing tumor response as a potential confounder), the differing rates of seizure improvement suggest that higher GKS doses are important in modifying epileptogenic changes in cortex adjacent to tumor. Arteriovenous Malformations The potential efficacy of GKS in the treatment of symptomatic localization-related epilepsies is most evident in the treatment of AVM (Table 1). Representative is the large series accumulated by Steiner et al, 11 who reported that seizures remit after GKS in 69% of patients with AVM and epilepsy. Subsequent studies of both proton beam treatment and GKS show a combined rate of seizure remission of approximately 70% (Table 1). A recent large case series emphasized that the incidence of seizure remission is better with smaller AVMs. 14 However, Steiner et al 11 noted that seizures remitted independent of radiologic remission of the AVM, a finding that suggests that the effects of irradiation near the lesion, rather than the improvement of the AVM itself, may be important in control of seizures after GKS. Cavernous Malformations With the favorable results encountered in treatment of seizures associated with AVMs and tumors, investiga- 178
3 Table 1. Seizure Remission After Stereotactic Radiosurgery of Arteriovenous Malformations, Hypothalamic Hamartomas, and Cavernous Malformations a Study No. of Patients Duration of Follow-up b Outcome c Remission, No. (%) Arteriovenous malformations Heikkinen et al, y Cessation 16 (55) Steiner et al, mo Cessation 41 (69) Gerszten et al, d mo Cessation 11 (73) Kurita et al, mo Cessation 28 (80) Schäuble et al, y EC, 4 48 (74) Total (71) Cavernous malformations Bartolomei et al, mo EC, 1 26 (53) Kim et al, mo Cessation 9 (75) Liscak et al, mo Cessation 20 (45) Liu et al, y EC, 4 15 (54) Shih and Pan, mo Cessation 4 (25) Total (50) Hypothalamic hamartomas Régis et al, mo Cessation 4 (40) Unger et al, mo Cessation 0 Selch et al, mo EC, 1 2 (67) Barajas et al, mo Cessation 0 Régis et al, y Cessation 10 (37) Mathieu et al, mo Cessation 0 Total (31) Abbreviation: EC, Engel class. a The study by Heikkinen et al 10 used a proton beam accelerator and the study by Selch et al 22 used a linear accelerator; all other studies used the Gamma Knife (Elekta AB, Stockholm, Sweden). b Reported as mean or range. c Definition of clinical seizure improvement. d Pediatric patients only. tors began to explore the efficacy of GKS in other epileptic lesions. Table 1 shows a summary of the efficacy of GKS in the treatment of seizures associated with cavernous malformations In general, seizure remission is lower than that encountered in cases after treatment of AVMs. The effect of dose to adjacent brain around the margin of the cavernous malformation, thought important in the case of tumors 9 and possibly AVMs, 11 has not been systematically studied in terms of seizure control (although higher doses may have more problems with radiotoxicity and lower doses with rebleeding). 19 Excess morbidity in terms of postoperative hemorrhage remains a concern. For example, the early Swedish experience determined that GKS did not appreciably alter the natural course of cavernous malformation while exposing patients to radiation-induced complications that exceeded by 7 times those expected for the same dose for AVMs. 26 A recent retrospective comparison concluded that traditional open resection resulted in better seizure control and rebleeding avoidance than did GKS. 19 Hypothalamic Hamartomas Hypothalamic hamartomas are an important cause of an epileptic encephalopathy marked by medically intractable gelastic and other seizures with behavioral and cognitive decline. Although HHs are difficult to excise with the use of standard surgical techniques, GKS has the advantage of providing noninvasive access while sparing adjacent tissue. Table 1 shows a summary of radiosurgical treatment of HHs Although the combined rate of 27% appears low, seizure remission alone underestimates the positive impact on overall morbidity and custodial care required in these cases of severe epilepsy. Behavioral outcomes have not been rigorously quantified, but every report on HHs in Table 1 notes that most patients experience marked improvement in behavior, sleep quality, and learning. In some cases, the treatment enables relatively normal participation in school. A European, multicenter, prospective trial of GKS for HHs has enrolled 60 patients, 27 of whom have exceeded 3 years of follow-up. 24 This study emphasizes the temporal evolution of seizure changes during the postoperative period. Within the first 2 months a slight improvement in seizure rate typically occurs. Seizures transiently worsen in frequency before reduction and remission occur. Behavioral improvements, along with electroencephalogram normalization, tend to occur in a more linear fashion. Morbidity is low, with no ill effects except for 1 instance of poikilothermia noted among the cases reported in Table 1. Some data also emphasize the importance of the marginal dose of radiation 24 as noted in tumors and AVMs. Patients treated with doses exceeding 17 Gy to the margin of HHs have greater rates of seizure remission than those receiving less than 13 Gy. 20 Use of GKS may be one of several nontraditional surgical approaches that can improve what is otherwise a devastating epileptic encephalopathy. 179
4 Table 2. Seizure Remission Rates (Defined as Engel Class 1) of Stereotactic Surgery for Mesial Temporal Lobe Epilepsy a Source No. of Patients Dose, Gy Volume, ml Lower Limit of Follow-up, mo Remission, No. (%) Régis et al (86) Cmelak et al 32b 1 15 NS 12 0 Kawai et al Srikijvilaikul et al McDonald et al NA Régis et al (62) Total (46) Abbreviations: NA, not applicable; NS, not specified. a All studies used the Gamma Knife (Elekta AB, Stockholm, Sweden). Treatment dose and volumes are estimated at the 50% isodose limit. b Linear accelerator; dose and volume at 57% isodose limit. TREATMENT OF PHYSIOLOGIC EPILEPSIES Mesial Temporal Lobe Epilepsy Mesial temporal lobe epilepsy consists of atrophy, specific neuronal loss, and gliosis within the limbic system, most notably within the amygdala-hippocampus. Mesial temporal lobe epilepsy is the most frequent cause of medically intractable epilepsy in adults. The rationale for its treatment with GKS is less compelling than in the disorders discussed earlier because MTLE is amenable to open surgery. Open surgery, however, has a small, but real, risk of perisurgical complications such as bleeding, infection, and postoperative pain. Second, open surgery is expensive. Although a formal cost comparison for epilepsy treatment has not been done, the average cost per patient for open microsurgery was nearly 50% more than that for GKS for treatment of similar disorders. 27 Third, some of the reported adverse events of temporal lobectomy involve changes in results of neuropsychological testing. Fourth, some patients are reluctant to undergo elective open surgery with required inpatient stay and general anesthesia despite proven efficacy. Thus, GKS may offer a noninvasive alternative to open surgery in the pursuit of less postsurgical morbidity and less cost. Unfortunately, initial attempts at epilepsy radiosurgery in Sweden were not encouraging. 28 Barcia et al 29 in 1994 described 11 patients treated for idiopathic focal epilepsy ; only 4 became seizure-free. Régis and colleagues 30 revived interest in GKS for MTLE in 1995 when their pilot studies showed high rates of seizure remission. Table 2 summarizes published cases; notably, all differ in treatment protocols and results, with most failing to achieve complete remission from seizures The variability in results of GKS therapy for MTLE underscores the difficulties in the determination of basic variables of anatomic target, dose, and target volume. Anatomic targets in GKS for MTLE are the least variable factor. All of the studies in Table 2 specify that the 50% isodose volume contains regions thought most important in the generation of mesial seizures: the amygdala, the head and anterior body of the hippocampus, and the parahippocampal gyrus (Figure 1). Dose and target volume are more variable. Comparison of the studies listed in Table 2 suggests that low-dose protocols are less successful than higher-dose protocols. Volumeresponse curves from preliminary studies by Régis demonstrate a relatively steep curve that separates ineffective treatment from excessive toxicity stemming from radiation-provoked edema (Figure 2) ( Jean Régis, MD, oral and written communication, October 17, 2005). Régis et al 36 outlined the typical postoperative course, and in most respects it follows the polyphasic course described after GKS for HHs. 24 No significant clinical or neuroimaging changes occur until 9 to 12 months after surgery. 30,31,36,37 Nearly all patients experience transient exacerbations in auras before seizures decrease or remit. 36 The most dramatic drop in seizure rate occurs between 12 and 18 months, coinciding with the development and resolution of maximal changes on magnetic resonance images (Figure 3). Other morbidities reported by Régis et al 36 include visual field deficits in 52% of patients, mostly quadrantanopia as usual after standard anterior temporal lobectomy. One subject had a hemianopia (indicating direct involvement of the optic tract) and another had mixed deficits. 36 Other transient minor morbidities consisted of headache, nausea, vomiting, and depression. Headache requires special comment because it coincides in some subjects with postoperative edema. 36 Corticosteroids, given in response to headache, visual field changes, or magnetic resonance imaging changes, were used in most of the patients included in Table 2, but no clear evidence supports specific guidelines for corticosteroid initiation, its effectiveness in treating symptoms, or its effects on eventual seizure remission. In fact, Régis et al 36 reported that 38% of subjects were not treated with corticosteroids at any point in the postoperative course. One important factor in consideration of GKS compared with open surgery is that the delayed effect of treatment may expose patients to the continued morbidity of ongoing seizures, including sudden unexpected death in epilepsy and traumatic injury. Two deaths occurred during the latency period in a case series of 5 patients treated with low-dose radiation 34 (Table 2). Allowing enough time for maturation of the radiosurgical lesion may have allowed some patients treated with lower doses to demonstrate remission, given that animal models treated with lower doses demonstrated improvements at a slower rate than those treated with higher doses. 5,6 Future trials of GKS may need to consider supplementary seizure pro- 180
5 S 8 Gy 10 Gy R 24 Gy R 8 Gy 10 Gy 24 Gy SP:276. z: A Sagittal S 8 Gy 10 Gy 24 Gy A Reconstructed, x: 86.1 OpenBook Figure 1. A screen capture of Gamma Knife (Elekta AB, Stockholm, Sweden) planning for a patient with right mesial temporal lobe epilepsy. The 50% isodose lines (yellow) delineate the treatment volume that contains the amygdala, anterior 2 cm of the hippocampus, and the parahippocampal gyrus that will be exposed to at 50% of a total treatment of 24 Gy. Green lines indicate 8 to 10 Gy 50% isodose lines so as to limit radiation exposure to brainstem or optic nerve. Note that the treatment volume excludes the brainstem and optic nerve from excessive radiation exposure. To achieve this plan, 6 separate dose isocenters created the complex shape required. phylaxis during the period of transient exacerbation of auras and seizures. Beyond seizure efficacy, studies have begun to evaluate secondary outcome measures such as cognition and quality of life. Epileptic rats demonstrate no behavioral effects attributable to GKS. 5 In humans, 3 reports of neuropsychological outcome after GKS for MTLE are available: the previously noted prospective, multicenter trial 36 and 2 studies of small series of participants. 34,35 Prospective trial results report no mean neurocognitive changes through a 2-year follow-up period. 36 Similarly, Srikijvilaikul et al 34 reported no group mean changes at 6 months of follow-up, although some individuals showed decline in at least 1 cognitive domain. McDonald et al 35 reported on 27-month follow-up in 3 participants who underwent dominant-hemisphere low-dose GKS treatment. No long-term consistent changes in neurocognitive measures were found, although each patient showed decline in a measure of verbal memory. They concluded that neurocognitive changes after GKS appeared similar to those of anterior temporal lobectomy. In summary, GKS for MTLE appears to have promise, but dose and relative benefits have yet to be clearly demarcated from those of open surgery. A National Institutes of Health sponsored multicenter pilot study on the safety of GKS for MTLE has recently been completed. In that study, patients who would normally qualify for anterior temporal lobectomy for unilateral MTLE were randomized to either a 20- or 24-Gy dose. A total of 30 subjects were enrolled and followed up for 3 years. Preliminary results are promising, with safety well within that expected after routine GKS with favorable efficacy and neuropsychological profiles. Edema Scale Isodose Volume, ml Other Nonlesional Epilepsies Not seizure-free Seizure-free Figure 2. Volume-dose relationships of preliminary studies of Gamma Knife (Elekta AB, Stockholm, Sweden) treatment of mesial temporal lobe epilepsy 30,31 (unpublished data courtesy of Jean Régis, MD, October 17, 2005). Volume along the x-axis denotes the 50% isodose volume with treatment doses of either 20 or 24 Gy, and on the y-axis a 5-point scale denotes the qualitative severity of magnetic resonance imaging changes due to Gamma Knife surgery. A narrow window ranging from 5.5 to 7.0 ml defines a breakpoint between low remission of seizures and excess toxic effects as determined by magnetic resonance imaging. There are no published data on the use of GKS for nonlesional neocortical foci. Because localization of seizure onset in these cases usually requires invasive techniques, the noninvasive nature of GKS loses some advantage. One may speculate that, if noninvasive localization and brain mapping were rigorous enough to identify foci and function of the neocortex, GKS may have a future role. 181
6 Baseline 6 mo 12 mo 24 mo Figure 3. Serial magnetic resonance imaging changes (top row, T2 weighted; bottom row, fluid-attenuated inversion recovery) in a representative patient with right mesial temporal lobe epilepsy who was treated with 20 Gy in the prospective National Institutes of Health sponsored trial of Gamma Knife surgery for unilateral mesial temporal lobe epilepsy. As described in earlier reports, 36 high-intensity changes and swelling representing reactive edema develop at and around the surgical target at approximately 9 to 12 months after surgery. Auras may worsen between 6 and 12 months, and frank seizures begin to remit at around the same interval. Edema resolves by 24 months after surgery, leaving behind a small region of tissue loss and trace high-intensity signal within the target. Resection of the corpus callosum decreases the severity and number of primary generalized or rapidly propagating secondarily generalized seizures in patients who are not otherwise good surgical candidates. Small case series report that improvement in seizures after GKS resection of the corpus callosum was comparable to that reported after open callosotomy, with lack of notable complications. 38,39 The future role of GKS in corpus callosotomy may be more difficult to determine because the effectiveness of vagal nerve stimulation makes surgery a less attractive option. CONCLUSIONS In summary, GKS offers an alternative to open surgery in selected patients with epilepsy caused by mass lesions such as tumors or AVMs. The choice between open and noninvasive surgery, however, should still be guided by the difficulties presented by the lesion rather than any epilepsy-specific characteristics of either surgical technique. On the other hand, GKS for the seizures arising from cavernous malformations appears to have a less than enthusiastic endorsement, given some studies findings of excessive rebleeding. In contrast, GKS for HHs appears promising given the combination of inaccessibility to traditional surgery, severe morbidity of gelastic epilepsy, and good safety profile. Finally, recent trials suggest that certain protocols of GKS for MTLE may offer a noninvasive alternative to open surgery while yielding similar rates of seizure remission and favorable neuropsychological outcomes. Further work is needed to clarify whether remission rates or neurocognitive outcomes after GKS are comparable to those after anterior temporal lobectomy. One distinct disadvantage of GKS is the latency period required while the radiosurgical lesion develops. However, the noninvasive nature of GKS may prove to be an advantage to those who fear craniotomy or those with comorbid medical conditions that may prevent full anesthesia. Accepted for Publication: February 18, Correspondence: Mark Quigg, MD, MSc, Department of Neurology, PO Box , HSC, University of Virginia, Charlottesville, VA (quigg@virginia.edu). Author Contributions: Analysis and interpretation of data: Quigg and Barbaro. Drafting of the manuscript: Quigg and Barbaro. Critical revision of the manuscript for important intellectual content: Quigg and Barbaro. Financial Disclosure: The authors report receiving grant support from the National Institutes of Health and support from Elekta AB. Role of the Sponsor: Data derived from the support by the National Institutes of Health and Elekta AB are not discussed in this review. Additional Contributions: Ladislau Steiner, MD, Department of Neurological Surgery, University of Virginia, provided early guidance and support in past and ongoing projects and provided Gamma Knife planning graphics. REFERENCES 1. Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand. 1951;102(4):
7 2. Ferland RJ, Williams JP, Gross RA, Applegate CD. The effects of brain-irradiationinduced decreases in hippocampal mitotic activity on flurothyl-induced epileptogenesis in adult C57BL/6J mice. Exp Neurol. 2003;179(1): Sun B, DeSalles AA, Medin PM, et al. Reduction of hippocampal-kindled seizure activity in rats by stereotactic radiosurgery. Exp Neurol. 1998;154(2): Chen ZF, Kamiryo T, Henson SL, et al. Anticonvulsant effects of gamma surgery in a model of chronic spontaneous limbic epilepsy in rats. J Neurosurg. 2001; 94(2): Maesawa S, Kondziolka D, Dixon CE, Balzer J, Fellows W, Lunsford LD. Subnecrotic stereotactic radiosurgery controlling epilepsy produced by kainic acid injection in rats. J Neurosurg. 2000;93(6): Mori Y, Kondziolka D, Balzer J, et al. Effects of stereotactic radiosurgery on an animal model of hippocampal epilepsy. Neurosurgery. 2000;46(1): Tsuchitani S, Drummond J, Kamiryo T, et al. Selective vulnerability of interneurons to low dosage radiosurgery. Abstract presented at: Society for Neuroscience Annual Meeting; November 8-12, 2003; New Orleans, LA. 8. Jenrow KA, Ratkewicz AE, Elisevich KV. Enhanced excitability induced by ionizing radiation in the kindled rat. Exp Neurol. 2001;169(1): Schröttner O, Eder HG, Unger F, Feichtinger K, Pendl G. Radiosurgery in lesional epilepsy: brain tumors. Stereotact Funct Neurosurg. October 1998;70(suppl 1): Heikkinen ER, Konnov B, Melnikov L, et al. Relief of epilepsy by radiosurgery of cerebral arteriovenous malformations. Stereotact Funct Neurosurg. 1989;53 (3): Steiner L, Lindquist C, Adler JR, Torner JC, Alves W, Steiner M. Clinical outcome of radiosurgery for cerebral arteriovenous malformations. J Neurosurg. 1992;77(1): Gerszten PC, Adelson PD, Kondziolka D, Flickinger JC, Lunsford LD. Seizure outcome in children treated for arteriovenous malformations using gamma knife radiosurgery. Pediatr Neurosurg. 1996;24(3): Kurita H, Kawamoto S, Suzuki I, et al. Control of epilepsy associated with cerebral arteriovenous malformations after radiosurgery. J Neurol Neurosurg Psychiatry. 1998;65(5): Schäuble B, Cascino GD, Pollock BE, et al. Seizure outcomes after stereotactic radiosurgery for cerebral arteriovenous malformations. Neurology. 2004;63 (4): Bartolomei F, Régis J, Kida Y, et al. Gamma Knife radiosurgery for epilepsy associated with cavernous hemangiomas: a retrospective study of 49 cases. Stereotact Funct Neurosurg. 1999;72(suppl 1): Kim MS, Pyo SY, Jeong YG, Lee SI, Jung YT, Sim JH. Gamma Knife surgery for intracranial cavernous hemangioma. J Neurosurg. 2005;102(suppl): Liscák R, Vladyka V, Simonova G, Vymazal J, Novotny J Jr. Gamma Knife surgery of brain cavernous hemangiomas. J Neurosurg. January 2005;102(suppl): Liu KD, Chung WY, Wu HM, et al. Gamma Knife surgery for cavernous hemangiomas: an analysis of 125 patients. J Neurosurg. January 2005;102(suppl): Shih YH, Pan DH. Management of supratentorial cavernous malformations: craniotomy versus gammaknife radiosurgery. Clin Neurol Neurosurg. 2005;107 (2): Régis J, Bartolomei F, de Toffol B, et al. Gamma knife surgery for epilepsy related to hypothalamic hamartomas. Neurosurgery. 2000;47(6): Unger F, Schröttner O, Feichtinger M, Bone G, Haselsberger K, Sutter B. Stereotactic radiosurgery for hypothalamic hamartomas. Acta Neurochir Suppl (Wien). 2002;84: Selch MT, Gorgulho A, Mattozo C, Solberg TD, Cabatan-Awang C, DeSalles AA. Linear accelerator stereotactic radiosurgery for the treatment of gelastic seizures due to hypothalamic hamartoma. Minim Invasive Neurosurg. 2005;48 (5): Barajas MA, Ramirez-Guzman MG, Rodriguez-Vazquez C, Toledo-Buenrostro V, Cuevas-Solorzano A, Rodriguez-Hernandez G. Gamma knife surgery for hypothalamic hamartomas accompanied by medically intractable epilepsy and precocious puberty: experience in Mexico. J Neurosurg. January 2005;102(suppl): Régis J, Scavarda D, Tamura M, et al. Epilepsy related to hypothalamic hamartomas: surgical management with special reference to gamma knife surgery. Childs Nerv Syst. 2006;22(8): Mathieu D, Kondziolka D, Niranjan A, Flickinger J, Lunsford LD. Gamma knife radiosurgery for refractory epilepsy caused by hypothalamic hamartomas. Stereotact Funct Neurosurg. 2006;84(2-3): Karlsson B, Kihlstrom L, Lindquist C, Ericson K, Steiner L. Radiosurgery for cavernous malformations. J Neurosurg. 1998;88(2): Wellis G, Nagel R, Vollmar C, Steiger HJ. Direct costs of microsurgical management of radiosurgically amenable intracranial pathology in Germany: an analysis of meningiomas, acoustic neuromas, metastases and arteriovenous malformations of less than 3 cm in diameter. Acta Neurochir (Wien). 2003;145(4): Lindquist C, Kilstrom L, Hellestrand E. Functional neurosurgery a future for the gamma knife? Stereotact Funct Neurosurg. 1991;57(1-2): Barcia JA, Barcia-Salorio JL, Lopez-Gomez L, Hernandez G. Stereotactic radiosurgery may be effective in the treatment of idiopathic epilepsy: report on the methods and results in a series of eleven cases. Stereotact Funct Neurosurg. 1994; 63(1-4): Régis J, Peragui J, Rey M, et al. First selective amygdalohippocampal radiosurgery for mesial temporal lobe epilepsy. Stereotact Funct Neurosurg. 1995; 64(suppl 1): Régis J, Bartolomei F, Rey M, et al. Gamma knife surgery for mesial temporal lobe epilepsy. Epilepsia. 1999;40(11): Cmelak AJ, Abou-Khalil B, Konrad PE, Duggan D, Maciunas RJ. Low-dose stereotactic radiosurgery is inadequate for medically intractable mesial temporal lobe epilepsy: a case report. Seizure. 2001;10(6): Kawai K, Suzuki I, Kurita H, Shin M, Arai N, Kirino T. Failure of low-dose radiosurgery to control temporal lobe epilepsy. J Neurosurg. 2001;95(5): Srikijvilaikul T, Najm I, Foldvary-Schaefer N, Lineweaver T, Suh JH, Bingaman WE. Failure of gamma knife radiosurgery for mesial temporal lobe epilepsy: report of five cases. Neurosurgery. 2004;54(6): McDonald CR, Norman MA, Tecoma E, Alksne J, Iragui V. Neuropsychological change following gamma knife surgery in patients with left temporal lobe epilepsy: a review of three cases. Epilepsy Behav. 2004;5(6): Régis J, Rey M, Bartolomei F, et al. Gamma knife surgery in mesial temporal lobe epilepsy: a prospective multicenter study. Epilepsia. 2004;45(5): Régis J, Semah F, Bryan RN, et al. Early and delayed MR and PET changes after selective temporomesial radiosurgery in mesial temporal lobe epilepsy. AJNR Am J Neuroradiol. 1999;20(2): Eder HG, Feichtinger M, Pieper T, Kurschel S, Schroettner O. Gamma knife radiosurgery for callosotomy in children with drug-resistant epilepsy. Childs Nerv Syst. 2006;22(8): Pendl G, Eder HG, Schroettner O, Leber KA. Corpus callosotomy with radiosurgery. Neurosurgery. 1999;45(2):
Review Article Gamma Knife Radiosurgery for Mesial Temporal Lobe Epilepsy
Epilepsy Research and Treatment Volume 2011, Article ID 840616, 5 pages doi:10.1155/2011/840616 Review Article Gamma Knife Radiosurgery for Mesial Temporal Lobe Epilepsy John D. Rolston, 1 Mark Quigg,
More informationSeizure control of Gamma Knife radiosurgery for non-hemorrhagic arteriovenous malformations
Acta Neurochir Suppl (2006) 99: 97 101 # Springer-Verlag 2006 Printed in Austria Seizure control of Gamma Knife radiosurgery for non-hemorrhagic arteriovenous malformations Y. J. Lim, C. Y. Lee, J. S.
More informationEPILEPSY. New Ideas about an Old Disease. Gregory D. Cascino, MD
EPILEPSY New Ideas about an Old Disease Gregory D. Cascino, MD Disclosure Research-Educational Grants Neuro Pace, Inc. American Epilepsy Society American Academy of Neurology Neurology (Associate Editor)
More informationChapter 28 Emerging Indications in Stereotactic Radiosurgery: The First Application of Cellular Surgery
Chapter 28 Emerging Indications in Stereotactic Radiosurgery: The First Application of Cellular Surgery Douglas Kondziolka, M.D., M.Sc., F.R.C.S.C., L. Dade Lunsford, M.D., John C. Flickinger, M.D., and
More informationDelayed Radiation Necrosis With Extensive Brain Edema After Gamma Knife Radiosurgery for Multiple Cerebral Cavernous Malformations
Neurol Med Chir (Tokyo) 43, 391 395, 2003 Delayed Radiation Necrosis With Extensive Brain Edema After Gamma Knife Radiosurgery for Multiple Cerebral Cavernous Malformations Case Report Nobuo TAKENAKA,
More informationMesial temporal lobe epilepsy (TLE) with hippocampal
» This article has been updated from its originally published version to correct the affiliations. See the corresponding erratum notice; DOI: 10.3171/2017.5.JNS141280a. «CLINICAL ARTICLE J Neurosurg 123:1375
More informationIntracranial Studies Of Human Epilepsy In A Surgical Setting
Intracranial Studies Of Human Epilepsy In A Surgical Setting Department of Neurology David Geffen School of Medicine at UCLA Presentation Goals Epilepsy and seizures Basics of the electroencephalogram
More informationDECISION MAKING IN AVM TREATMENT STRATEGY TREATMENT BOARD SYSTEM AT TOHOKU UNIVERSITY
Kitakanto Med. J. (S1) : 79-84, 1998 79 DECISION MAKING IN AVM TREATMENT STRATEGY TREATMENT BOARD SYSTEM AT TOHOKU UNIVERSITY Takashi Yoshimoto, Hidefumi Jokura Department of Neurosurgery, Tohoku University
More informationClinical Commissioning Policy: Arteriovenous Malformations. December Reference : NHSCB/D5/4
Clinical Commissioning Policy: Arteriovenous Malformations December 2012 Reference : NHSCB/D5/4 NHS Commissioning Board Clinical Commissioning Policy: Arteriovenous Malformations First published: December
More informationMultimodal Imaging in Extratemporal Epilepsy Surgery
Open Access Case Report DOI: 10.7759/cureus.2338 Multimodal Imaging in Extratemporal Epilepsy Surgery Christian Vollmar 1, Aurelia Peraud 2, Soheyl Noachtar 1 1. Epilepsy Center, Dept. of Neurology, University
More informationDo seizures beget seizures?
Does MTLE cause progressive neurocognitive damage? Andrew Bleasel Westmead Do seizures beget seizures? The tendency of the disease is toward self-perpetuation; each attack facilitates occurrence of another
More informationANALYSIS OF TREATMENT OUTCOMES WITH LINAC BASED STEREOTACTIC RADIOSURGERY IN INTRACRANIAL ARTERIOVENOUS MALFORMATIONS
ANALYSIS OF TREATMENT OUTCOMES WITH LINAC BASED STEREOTACTIC RADIOSURGERY IN INTRACRANIAL ARTERIOVENOUS MALFORMATIONS Dr. Maitri P Gandhi 1, Dr. Chandni P Shah 2 1 Junior resident, Gujarat Cancer & Research
More informationLong-term and late seizure outcome after surgery for temporal lobe epilepsy
Original article Epileptic Disord 2010; 12 (1): 54-8 Long-term and late seizure outcome after surgery for temporal lobe epilepsy José Pimentel 1, Carla Bentes 1,2, Alexandre Campos 3, A. Gonçalves Ferreira
More informationThe Use of Stereotactic Radiosurgery to Treat Intractable Childhood Partial Epilepsy
Epilepsia, 43(3):292 300, 2002 Blackwell Publishing, Inc. International League Against Epilepsy The Use of Stereotactic Radiosurgery to Treat Intractable Childhood Partial Epilepsy *Catalina Dunoyer, John
More informationSEIZURE OUTCOME AFTER EPILEPSY SURGERY
SEIZURE OUTCOME AFTER EPILEPSY SURGERY Prakash Kotagal, M.D. Head, Pediatric Epilepsy Cleveland Clinic Epilepsy Center LEFT TEMPORAL LOBE ASTROCYTOMA SEIZURE OUTCOME 1 YEAR AFTER EPILEPSY SURGERY IN ADULTS
More informationRadiosurgery versus open surgery for mesial temporal lobe epilepsy: The randomized, controlled ROSE trial
Accepted: 14 February 2018 DOI: 10.1111/epi.14045 FULL-LENGTH ORIGINAL RESEARCH Radiosurgery versus open surgery for mesial temporal lobe epilepsy: The randomized, controlled ROSE trial Nicholas M. Barbaro
More informationMicrosurgical Resection of Incompletely Obliterated Intracranial Arteriovenous Malformations Following Stereotactic Radiosurgery
II-2. Selection of Treatment Microsurgical Resection of Incompletely Obliterated Intracranial Arteriovenous Malformations Following Stereotactic Radiosurgery Steven D. CHANG*, Gary K. STEINBERG*, Richard
More informationCurative effect and costs of surgical and gamma knife treatments on intractable epilepsy caused by temporal-hippocampal sclerosis
Curative effect and costs of surgical and gamma knife treatments on intractable epilepsy caused by temporal-hippocampal sclerosis Z.T. Han and Q.X. Chen Neurosurgery Department, Renmin Hospital of Wuhan
More informationPRESURGICAL EVALUATION. ISLAND OF COS Hippocrates: On the Sacred Disease. Disclosure Research-Educational Grants. Patients with seizure disorders
PRESURGICAL EVALUATION Patients with seizure disorders Gregory D. Cascino, MD Mayo Clinic Disclosure Research-Educational Grants Mayo Foundation Neuro Pace, Inc. American Epilepsy Society American Academy
More informationOtolaryngologist s Perspective of Stereotactic Radiosurgery
Otolaryngologist s Perspective of Stereotactic Radiosurgery Douglas E. Mattox, M.D. 25 th Alexandria International Combined ORL Conference April 18-20, 2007 Acoustic Neuroma Benign tumor of the schwann
More informationGamma Knife Radiosurgery
Gamma Knife Radiosurgery A Team Approach to Treating Patients George Bovis, MD Patrick Sweeney, MD Jagan Venkatesan, MS Matt White, MS Illinois Gamma Knife Center Elk Grove Village, IL Disclosures Shareholders
More informationSerial Follow-up MR Imaging after Gamma Knife Radiosurgery for Vestibular Schwannoma
AJNR Am J Neuroradiol 21:1540 1546, September 2000 Serial Follow-up MR Imaging after Gamma Knife Radiosurgery for Vestibular Schwannoma Hiroyuki Nakamura, Hidefumi Jokura, Kou Takahashi, Nagatoshi Boku,
More informationSurgical Treatment of Epilepsy
Presurgical Assessment and the Surgical Treatment of Epilepsy Michael C., MD Director, Rush Epilepsy Center Associate Professor and Senior Attending Neurologist Rush University Medical Center Chicago,
More informationForward treatment planning techniques to reduce the normalization effect in Gamma Knife radiosurgery
Received: 7 November 2016 Revised: 9 August 2017 Accepted: 21 August 2017 DOI: 10.1002/acm2.12193 RADIATION ONCOLOGY PHYSICS Forward treatment planning techniques to reduce the normalization effect in
More informationIMAGE-GUIDED RADIOSURGERY USING THE GAMMA KNIFE
IMAGE-GUIDED RADIOSURGERY USING THE GAMMA KNIFE L. D. LUNSFORD INTRODUCTION Image guided brain surgery became a reality in the mid-1970s after the introduction of the first methods to obtain axial imaging
More informationPREDICTION OF COMPLICATIONS IN GAMMA KNIFE RADIOSURGERY OF ARTERIOVENOUS MALFORMATIONS
Acta Oncologica Vol. 35, No. I, pp. 49-55, 1996 PREDICTION OF COMPLICATIONS IN GAMMA KNIFE RADIOSURGERY OF ARTERIOVENOUS MALFORMATIONS INGMAR LAX and BENGT KARLSSON The incidence of complications following
More informationA lthough more than 90% of intracranial meningiomas are
226 PAPER Complications after gamma knife radiosurgery for benign meningiomas J H Chang, J W Chang, J Y Choi, Y G Park, S S Chung... See end of article for authors affiliations... Correspondence to: Professor
More informationDespite recent progress in microsurgical techniques, endovascular
Application of Single-Stage Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations >10 cm 3 Shunya Hanakita, MD; Tomoyuki Koga, MD, PhD; Masahiro Shin, MD, PhD; Hiroshi Igaki, MD, PhD; Nobuhito
More informationSelected radiosurgery cases from the Rotating Gamma Institute Debrecen, Hungary
Selected radiosurgery cases from the Rotating Gamma Institute Debrecen, Hungary László Bognár M.D., Ph.D., József G. Dobai M.D., Gábor Csiky and Imre Fedorcsák M.D., Ph.D. Department of Neurosurgery, Medical
More informationEstimating the Risks of Adverse Radiation Effects After Gamma Knife Radiosurgery for Arteriovenous Malformations
Estimating the Risks of Adverse Radiation Effects After Gamma Knife Radiosurgery for Arteriovenous Malformations Hideyuki Kano, MD, PhD; John C. Flickinger, MD; Daniel Tonetti, MD; Alan Hsu, MD; Huai-che
More informationLong term neuroimaging and clinical outcome of brain Arteriovenous Malformations (bavm) treated with stereotactic radiosurgery (SRS).
Long term neuroimaging and clinical outcome of brain Arteriovenous Malformations (bavm) treated with stereotactic radiosurgery (SRS). Poster No.: C-2489 Congress: ECR 2012 Type: Scientific Exhibit Authors:
More informationLong-term results of gamma knife surgery for growth hormone producing pituitary adenoma: is the disease difficult to cure?
J Neurosurg (Suppl) 102:119 123, 2005 Long-term results of gamma knife surgery for growth hormone producing pituitary adenoma: is the disease difficult to cure? TATSUYA KOBAYASHI, M.D., PH.D., YOSHIMASA
More informationHigh Resolution Ictal SPECT: Enhanced Epileptic Source Targeting?
High Resolution Ictal SPECT: Enhanced Epileptic Source Targeting? Marvin A Rossi MD, PhD RUSH Epilepsy Center Research Lab http://www.synapticom.net Chicago, IL USA Medically-Refractory Epilepsy 500,000-800,000
More informationThe Changing Surgical Landscape in Kids
The Changing Surgical Landscape in Kids December 7, 2013 Howard L. Weiner, MD NYU Langone Medical Center American Epilepsy Society Annual Meeting Disclosure none American Epilepsy Society 2013 Annual Meeting
More informationApproximately 70% of childhood SURGICAL TREATMENTS FOR PEDIATRIC EPILEPSY PROCEEDINGS. Ronald P. Lesser, MD KEY POINTS
ASIM May p153-158 5/14/01 9:19 AM Page 153 SURGICAL TREATMENTS FOR PEDIATRIC EPILEPSY Ronald P. Lesser, MD KEY POINTS Most children with epilepsy refractory to drugs can improve with surgery Temporal lobe
More informationSubject: Magnetoencephalography/Magnetic Source Imaging
01-95805-16 Original Effective Date: 09/01/01 Reviewed: 07/26/18 Revised: 08/15/18 Subject: Magnetoencephalography/Magnetic Source Imaging THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION, CERTIFICATION,
More informationS tereotactic radiosurgery, whether delivered by a gamma
1536 PAPER Gamma knife stereotactic radiosurgery for unilateral acoustic neuromas J G Rowe, M W R Radatz, L Walton, A Hampshire, S Seaman, A A Kemeny... See end of article for authors affiliations... Correspondence
More informationGamma Knife radiosurgery with CT image-based dose calculation
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 16, NUMBER 6, 2015 Gamma Knife radiosurgery with CT image-based dose calculation Andy (Yuanguang) Xu, 1a Jagdish Bhatnagar, 1 Greg Bednarz, 1 Ajay Niranjan,
More informationEpilepsy. Seizures and Epilepsy. Buccal Midazolam vs. Rectal Diazepam for Serial Seizures. Epilepsy and Seizures 6/18/2008
Seizures and Epilepsy Paul Garcia, M.D. UCSF Epilepsy Epileptic seizure: the physical manifestation of aberrant firing of brain cells Epilepsy: the tendency to recurrent, unprovoked epileptic seizures
More informationDosimetry of the Gamma Knife TM
Dosimetry of the Gamma Knife TM Sheridan Griffin Meltsner, Ph.D. Aurora Health Care St. Luke s Medical Center NCCAAPM Spring Meeting Outline Introduction to stereotactic radiosurgery Elekta Gamma Knife
More informationGamma. Knife PERFEXION. care. World-class. The Gamma Knife Program at Washington Hospital
The Gamma Knife Program at Washington Hospital PERFEXION Fast, precise, minimally invasive treatment for neurological conditions. Locally based care by internationally Gamma recognized experts. World-class
More informationLeksell Gamma Knife References 1992 December Gamma Knife Radiosurgery
Leksell Gamma Knife References 1992 December 2011 Gamma Knife Radiosurgery Vascular Malformation Bibliography 2006-2016 VASCULAR MALFORMATIONS Includes Gamma Knife-focused abstracts posted to PubMed during
More informationMetabolite and Diffusion Changes in the Rat Brain After Leksell Gamma Knife Irradiation
NOTES Magnetic Resonance in Medicine 52:397 402 (2004) Metabolite and Diffusion Changes in the Rat Brain After Leksell Gamma Knife Irradiation Vít Herynek, 1 * Martin Burian, 1,2 Daniel Jirák, 1,2 Roman
More informationNeurosurgery. Neurosurgery
Neurosurgery Neurosurgery Neurosurgery Telephone Numbers: Appointment: 202-476-3020 Fax: 202-476-3091 Administration: 202-476-3020 Evenings and Weekends: 202-476-5000 Robert Keating, MD, Chief The Division
More informationRotating and static sources for gamma knife radiosurgery systems: Monte Carlo studies
Rotating and static sources for gamma knife radiosurgery systems: Monte Carlo studies J. Y. C. Cheung and K. N. Yu a Department of Physics and Materials Science, City University of Hong Kong, Kowloon Tong,
More informationSurgery for Medically Refractory Focal Epilepsy
Surgery for Medically Refractory Focal Epilepsy Seth F Oliveria, MD PhD The Oregon Clinic Neurosurgery Director of Functional Neurosurgery: Providence Brain and Spine Institute Portland, OR Providence
More informationStereotactic Diffusion Tensor Tractography For Gamma Knife Stereotactic Radiosurgery
Disclosures The authors of this study declare that they have no commercial or other interests in the presentation of this study. This study does not contain any use of offlabel devices or treatments. Stereotactic
More informationCurrent Concepts and Trends in Spinal Radiosurgery. Edward M. Marchan
Current Concepts and Trends in Spinal Radiosurgery Edward M. Marchan Spinal Neoplasia The spine is the most common site of skeletal metastatic disease. (70%) 40% of bony metastases involve the vertebrae
More informationStereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Policy Number: Original Effective Date: MM.05.008 05/12/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 04/01/2017
More informationOriginal Article Nepal Journal of Neuroscience 1:
Original Article Nepal Journal of Neuroscience 1:98-103, 2004 Initial Experience of Different Surgical Techniques in Temporal Lobe Epilepsy in Nepal Basant Pant, MD, PhD Prabin Shrestha, MBBS Pranaya Shrestha,
More information5/22/2009. Pediatric Neurosurgery Pediatric Neurology Neuroradiology Neurophysiology Neuropathology Neuropsychology
Current Surgical Treatment Strategies for the Management of Pediatric Epilepsy University of California, San Francisco Department of Neurological Surgery San Francisco, California Kurtis Ian Auguste, M.D.
More informationDOWNLOAD PDF RADIOSURGERY FOR CAVERNOUS MALFORMATIONS IN BASAL GANGLIA, THALAMUS AND BRAINSTEM KIDA, Y
Chapter 1 : Stereotactic radiosurgery for cavernous malformations â Mayo Clinic Most of the lesions were located in the brainstem, followed by the lobar region, cerebellum, thalamus, and basal ganglia
More informationNeurological Change after Gamma Knife Radiosurgery for Brain Metastases Involving the Motor Cortex
ORIGINAL ARTICLE Brain Tumor Res Treat 2016;4(2):111-115 / pissn 2288-2405 / eissn 2288-2413 http://dx.doi.org/10.14791/btrt.2016.4.2.111 Neurological Change after Gamma Knife Radiosurgery for Brain Metastases
More informationSurgical Modalities for Epilepsy Treatment. C.J. Bui, MD, FAANS Ochsner Neuroscience Symposium 2016
Surgical Modalities for Epilepsy Treatment C.J. Bui, MD, FAANS Ochsner Neuroscience Symposium 2016 Conflict of Interest Nothing to disclose Surgical Modalities Diagnostic Subdural Grids Depth Electrodes
More informationInterictal High Frequency Oscillations as Neurophysiologic Biomarkers of Epileptogenicity
Interictal High Frequency Oscillations as Neurophysiologic Biomarkers of Epileptogenicity December 10, 2013 Joyce Y. Wu, MD Associate Professor Division of Pediatric Neurology David Geffen School of Medicine
More informationThe Risk of Hemorrhage after Radiosurgery for Cerebral Arteriovenous Malformations
The new england journal of medicine original article The Risk of Hemorrhage after Radiosurgery for Cerebral Arteriovenous Malformations Keisuke Maruyama, M.D., Nobutaka Kawahara, M.D., Ph.D., Masahiro
More informationStereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Policy Number: Original Effective Date: MM.05.008 05/12/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 03/01/2013 Section:
More informationEditorial. Radiosurgery in cavernous malformations: anatomy of a controversy
See the corresponding article in this issue, pp 23 29. J Neurosurg 113:16 22, 2010 Editorial Radiosurgery in cavernous malformations: anatomy of a controversy La d i s l a u St e i n e r, M.D., Ph.D.,
More informationEMG, EEG, and Neurophysiology in Clinical Practice
Mayo School of Continuous Professional Development EMG, EEG, and Neurophysiology in Clinical Practice Matthew T. Hoerth, M.D. Ritz-Carlton, Amelia Island, Florida January 29-February 4, 2017 2016 MFMER
More informationEPILEPSY SURGERY- SURGICAL PROCEDURES
EPILEPSY SURGERY- SURGICAL PROCEDURES When to consider epilepsy surgery? Persistent Seizures despite adequate pharmacological treatment Drug resistant epilepsy may be defined as failure of adequate trials
More informationEpilepsy Surgery: Who should be considered? How will patients do? Bassel Abou-Khalil, M.D.
Epilepsy Surgery: Who should be considered? How will patients do? Bassel Abou-Khalil, M.D. Disclosures none Self-assessment questions Q1- Which qualify for drug resistance in focal epilepsy? A. Failure
More informationORIGINAL PAPER USEFUL BASE PLATE TO SUPPORT THE HEAD DURING LEKSELL SKULL FRAME PLACEMENT IN GAMMA KNIFE PERFEXION RADIOSURGERY
Nagoya J. Med. Sci. 76. 27 ~ 33, 2014 ORIGINAL PAPER USEFUL BASE PLATE TO SUPPORT THE HEAD DURING LEKSELL SKULL FRAME PLACEMENT IN GAMMA KNIFE PERFEXION RADIOSURGERY HISATO NAKAZAWA 1,2, MSc; YOSHIMASA
More informationStereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Policy Number: Original Effective Date: MM.05.008 05/12/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 11/20/2015
More informationStereotactic Radiosurgery. Extracranial Stereotactic Radiosurgery. Linear accelerators. Basic technique. Indications of SRS
Stereotactic Radiosurgery Extracranial Stereotactic Radiosurgery Annette Quinn, MSN, RN Program Manager, University of Pittsburgh Medical Center Using stereotactic techniques, give a lethal dose of ionizing
More informationDosimetry, see MAGIC; Polymer gel dosimetry. Fiducial tracking, see CyberKnife radiosurgery
Subject Index Acoustic neuroma, neurofibromatosis type 2 complications 103, 105 hearing outcomes 103, 105 outcome measures 101 patient selection 105 study design 101 tumor control 101 105 treatment options
More informationClinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy
Clinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy Reference: NHS England xxx/x/x 1 Clinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy First published:
More informationRecently, GKS has been regarded as a major therapeutic. Nervus intermedius dysfunction following Gamma Knife surgery for vestibular schwannoma
J Neurosurg 118:566 570, 2013 AANS, 2013 Nervus intermedius dysfunction following Gamma Knife surgery for vestibular schwannoma Clinical article Seong-Hyun Park, M.D., 1 Kyu-Yup Lee, M.D., 2 and Sung-Kyoo
More informationExtracranial doses in stereotactic and conventional radiotherapy for pituitary adenomas
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 7, NUMBER 2, SPRING 2006 Extracranial doses in stereotactic and conventional radiotherapy for pituitary adenomas Thomas Samuel Ram, a Paul B. Ravindran,
More informationNeuromodulation in Epilepsy. Gregory C. Mathews, M.D., Ph.D.
Neuromodulation in Epilepsy Gregory C. Mathews, M.D., Ph.D. Disclosure There are no disclosures to share with regards to this presentation. Epilepsy Basics What is epilepsy? Partial versus generalized
More informationDiffusion Tensor Imaging 12/06/2013
12/06/2013 Beate Diehl, MD PhD FRCP University College London National Hospital for Neurology and Neurosurgery Queen Square London, UK American Epilepsy Society Annual Meeting Disclosure None Learning
More informationRadiosurgery by Leksell gamma knife. Josef Novotny, Na Homolce Hospital, Prague
Radiosurgery by Leksell gamma knife Josef Novotny, Na Homolce Hospital, Prague Radiosurgery - Definition Professor Lars Leksell The tools used by the surgeon must be adapted to the task and where the human
More informationManagement of medically refractory trigeminal neuralgia in patients with multiple sclerosis
Neurosurg Focus 18 (5):E13, 2005 Management of medically refractory trigeminal neuralgia in patients with multiple sclerosis JASON S. CHENG, B.S., RENE O. SANCHEZ-MEJIA, M.D., MARY LIMBO, B.A., MARIANN
More informationKEY WORDS gamma knife surgery metastatic brain tumor radiation injury tumor recurrence thallium-201 single-photon emission computerized tomography
J Neurosurg (Suppl) 102:266 271, 2005 Diagnostic value of thallium-201 chloride single-photon emission computerized tomography in differentiating tumor recurrence from radiation injury after gamma knife
More informationStereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Policy Number: 6.01.10 Last Review: 11/2013 Origination: 1/1989 Next Review: 11/2014 Policy Blue Cross and Blue Shield of Kansas City (Blue
More informationSeizure, second only to hemorrhage, is a common
CLINICAL ARTICLE J Neurosurg 126:845 851, 2017 Seizure outcomes after stereotactic radiosurgery for the treatment of cerebral arteriovenous malformations Benjamin J. Ditty, MD, Nidal B. Omar, MD, Paul
More informationCerebral structural lesions are found in approximately. Surgery of Intractable Temporal Lobe Epilepsy Presented with Structural Lesions
Original Article J Chin Med Assoc 2003;66:565-571 Surgery of Intractable Temporal Lobe Epilepsy Presented with Structural Lesions Yang-Hsin Shih 1 Jiang-Fong Lirng 2 Der-Jen Yen 3 Donald M. Ho 4 Chun-Hing
More informationORIGINAL ARTICLE. Hearing Loss and Changes in Transient Evoked Otoacoustic Emissions After Gamma Knife Radiosurgery for Acoustic Neurinomas
ORIGINAL ARTICLE Hearing Loss and Changes in Transient Evoked Otoacoustic Emissions After Gamma Knife Radiosurgery for Acoustic Neurinomas Francesco Ottaviani, MD; Cesare Bartolomeo Neglia, MD; Laura Ventrella,
More informationEmbryonic MGE Cells as a Treatment for Epilepsy December 1, 2012
Embryonic MGE Cells as a Treatment for Epilepsy December 1, 2012 Scott C. Baraban, PhD University of California, San Francisco American Epilepsy Society Annual Meeting Disclosure Name of Commercial Interest
More informationSurvival and Intracranial Control of Patients With 5 or More Brain Metastases Treated With Gamma Knife Stereotactic Radiosurgery
ORIGINAL ARTICLE Survival and Intracranial Control of Patients With 5 or More Brain Metastases Treated With Gamma Knife Stereotactic Radiosurgery Ann C. Raldow, BS,* Veronica L. Chiang, MD,w Jonathan P.
More informationInfluenced by the high morbidity and mortality associated
Hemorrhage Risk of Cerebral Arteriovenous Malformations Before and During the Latency Period After Gamma Knife Radiosurgery Chun-Po Yen, MD; Jason P. Sheehan, MD, PhD; Lucia Schwyzer, MD; David Schlesinger,
More informationUnruptured Epileptogenic Brain Arteriovenous Malformations
DOI: 10.5137/1019-5149.JTN.9190-13.1 Received: 31.08.2013 / Accepted: 24.09.2013 Published Online: 16.02.2016 Original Investigation Unruptured Epileptogenic Brain Arteriovenous Malformations Yong SUN
More informationDifficult-to-Localize Intractable Focal Epilepsy: An In-Depth Look
Current Literature In Clinical Science Difficult-to-Localize Intractable Focal Epilepsy: An In-Depth Look Stereoelectroencephalography in the Difficult to Localize Refractory Focal Epilepsy: Early Experience
More informationBrain AVM with Accompanying Venous Aneurysm with Intracerebral and Intraventricular Hemorrhage
Cronicon OPEN ACCESS EC PAEDIATRICS Case Report Brain AVM with Accompanying Venous Aneurysm with Intracerebral and Intraventricular Hemorrhage Dimitrios Panagopoulos* Neurosurgical Department, University
More informationCorpus callosotomy with gamma knife radiosurgery for a case of intractable generalised epilepsy
Clinical commentary Epileptic Disord 2011; 13 (2): 202-8 Corpus callosotomy with gamma knife radiosurgery for a case of intractable generalised epilepsy Mohammad Bodaghabadi 1, Mohammad Ali Bitaraf 2,
More informationEpilepsy & Behavior Case Reports
Epilepsy & Behavior Case Reports 1 (2013) 45 49 Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr Case Report Partial disconnection
More informationLeksell Gamma Knife Icon. Treatment information
Leksell Gamma Knife Icon Treatment information You may be feeling frightened or overwhelmed by your recent diagnosis. It can be confusing trying to process a diagnosis, understand a new and challenging
More informationEpilepsy. Hyunmi Choi, M.D., M.S. Columbia Comprehensive Epilepsy Center The Neurological Institute. Seizure
Epilepsy Hyunmi Choi, M.D., M.S. Columbia Comprehensive Epilepsy Center The Neurological Institute Seizure Symptom Transient event Paroxysmal Temporary physiologic dysfunction Caused by self-limited, abnormal,
More informationTania Kaprealian, M.D. Assistant Professor UCLA Department of Radiation Oncology August 22, 2015
Tania Kaprealian, M.D. Assistant Professor UCLA Department of Radiation Oncology August 22, 2015 Most common brain tumor, affecting 8.5-15% of cancer patients. Treatment options: Whole brain radiation
More informationStaged-Volume Radiosurgery of Large AVMs
Case Study Staged-Volume Radiosurgery of Large AVMs Using Gamma Knife Technology Institution New York University Langone Medical Center Location New York City, NY Patient 18 patients Diagnosis Each patient
More informationEngland. Clinical Commissioning Policy: Radiosurgery/Radiotherapy for Cavernous Venous Malformations (Cavernomas)
Clinical Commissioning Policy: Radiosurgery/Radiotherapy for Cavernous Venous Malformations (Cavernomas) September 2013 Reference: NHS ENGLAND D05/P/g England 1 NHS England INFORMATION READER BOX Directorate
More informationSurgical treatment of hypothalamic hamartoma
Neurology Asia 2010; 15 (Supplement 1) : 15 20 Surgical treatment of hypothalamic hamartoma Young Seok Park MD, Yun Ho Lee MD, Kyu-Won Shim MD, Dong-Seok Kim MD PhD Department of Pediatric Neurosurgery,
More informationSUCCESSFUL TREATMENT OF METASTATIC BRAIN TUMOR BY CYBERKNIFE: A CASE REPORT
SUCCESSFUL TREATMENT OF METASTATIC BRAIN TUMOR BY CYBERKNIFE: A CASE REPORT Cheng-Ta Hsieh, 1 Cheng-Fu Chang, 1 Ming-Ying Liu, 1 Li-Ping Chang, 2 Dueng-Yuan Hueng, 3 Steven D. Chang, 4 and Da-Tong Ju 1
More information9/30/2016. Advances in Epilepsy Surgery. Epidemiology. Epidemiology
Advances in Epilepsy Surgery George Jallo, M.D. Director, Institute for Brain Protection Sciences Johns Hopkins All Children s Hospital St Petersburg, Florida Epidemiology WHO lists it as the second most
More informationEMBOLIZATION OF ARTERIOVENOUS FISTULA AFTER RADIOSURGERY FOR MULTIPLE CEREBRAL ARTERIOVENOUS MALFORMATIONS
Arteriovenous fistula after radiosurgery for multiple CAVM EMBOLIZATION OF ARTERIOVENOUS FISTULA AFTER RADIOSURGERY FOR MULTIPLE CEREBRAL ARTERIOVENOUS MALFORMATIONS Chao-Bao Luo, Wan-Yuo Guo, Michael
More informationOriginal Date: April 2016 Page 1 of 7 FOR CMS (MEDICARE) MEMBERS ONLY
National Imaging Associates, Inc. Clinical guidelines STEREOTACTIC RADIATION THERAPY: STEREO RADIOSURGERY (SRS) AND STEREOTACTIC BODY RADIATION THERAPY (SBRT) CPT4 Codes: Please refer to pages 5-6 LCD
More informationRadiosurgery for temporal lobe arteriovenous malformations: effect of temporal location on seizure outcomes
clinical article J Neurosurg 123:924 934, 2015 Radiosurgery for temporal lobe arteriovenous malformations: effect of temporal location on seizure outcomes Dale Ding, MD, 1 Mark Quigg, MD, MSc, 2 Robert
More informationAll patients with a diagnosis of treatment resistant (intractable) epilepsy.* Denominator Statement
MEASURE #7 Referral to Comprehensive Epilepsy Center Measure Description Percent of all patients with a diagnosis of treatment resistant (intractable) epilepsy who were referred for consultation to a comprehensive
More informationSmall and Big Operations: New Tools of the Trade for Brain Tumors. Disclosure. Incidence of Childhood Cancer
Small and Big Operations: New Tools of the Trade for Brain Tumors Nalin Gupta MD PhD Chief, Division of Pediatric Neurosurgery Departments of Neurosurgery and Pediatrics University of California San Francisco
More informationThe Asymmetric Mamillary Body: Association with Medial Temporal Lobe Disease Demonstrated with MR
The Mamillary Body: Association with Medial Temporal Lobe Disease Demonstrated with MR Alexander C. Mamourian, Lawrence Rodichok, and Javad Towfighi PURPOSE: To determine whether mamillary body atrophy
More information